| Response to ESAs Predicts ESRD Risk - Renal and Urology News |
|
|
Renal and Urology News PHILADELPHIA—Patients with chronic kidney disease (CKD) who have a low response to erythropoiesis-stimulating agents (ESAs) are at increased risk of progressing to end-stage renal disease (ESRD), investigators reported at Kidney Week 2011. |